Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Repeat PSA Test Recommended Before Prostate Biopsy

By HospiMedica staff writers
Posted on 12 Jun 2003
A study has found that levels of prostate-specific antigen (PSA) fluctuate in men, so that a moderately elevated level does not necessarily warrant a prostate biopsy. More...
The finding was reported in the May 28, 2003, issue of the Journal of the American Medical Association (JAMA).

The PSA blood test is part of routine screening for most men over 50, and when moderately elevated levels of PSA are found, a biopsy is currently recommended. In the retrospective study, involving 972 men with a median age of 62, researchers found that while 21% had an elevated PSA (> 4.0 ng/ml) at some point over a four-year period, the level later returned to normal in nearly 50% of the men and remained normal in further tests. As a result, the researchers suggest that a biopsy not be performed until the PSA test is repeated.

"A single, elevated PSA level does not automatically warrant a prostate biopsy,” said lead author Dr. James Eastham, a surgeon in the department of urology at Memorial Sloan-Kettering Cancer Center (New York, NY, USA). "We recommend having the findings confirmed by repeating the PSA test after waiting at least six weeks. Even if the repeat test shows an elevated level, prostate cancer will only be discovered in about one quarter of men who undergo biopsy.”


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Mammo DR Retrofit Solution
DR Retrofit Mammography
Hemostatic Agent
HEMOBLAST Bellows
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.